The global covid-19 diagnostics market size is anticipated to reach $17,203.38 million till the end of 2020. Covid-19 is an infectious disease caused by a newly discovered coronavirus with a nomenclature Sars Cov 2.The virus strain shows significant similarity with an earlier detected virus, Sars Cov. The virus outbreak started from Wuhan city of China and is now spread across 210 countries and territories around the world and 2 international conveyances, as per Worldometer data.

Significant increase in the incidences of covid-19 across the globe and rise in mortality rates due to the outbreak are the major factors that drive the market growth. Moreover, technological developments and introduction of various test kits by companies worldwide propels the market growth. However, dearth of diagnosis kits in developing economies is anticipated to hamper the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a fast pace.

KEY BENEFITS FOR STAKEHOLDERS

? This report provides a detailed quantitative analysis of the current Covid-19 diagnostics market trends and forecast estimations from 2020 to 2022, which assists to identify the prevailing market opportunities.
? An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
? A comprehensive analysis of factors that drive and restrain the covid-19 market growth is provided.
? The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2022, in terms of value.
? An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
? Key players within the market are profiled in this report and their strategies are analyzed thoroughly, which help in understanding competitive outlook.

KEY MARKET SEGMENTS
- By Product
o PCR Kits
o POC Kits
o Immuno Assay
By Technology
- Molecular
- Immunoassay
By End User
- Hospitals
- Physician's office and urgent care clinics
- Diagnostic Labs

By Region
o North America
- U.S.
- Canada
- Mexico
- Rest of North America
o Europe
- UK
- Germany
- France
- Spain
- Italy
- Estonia
- Austria
- Czech Republic
- Rest of Europe
o Asia-Pacific
- China
- India
- Australia
- Japan
- South Korea
- Thailand
- Malaysia
- Rest of Asia-Pacific
o LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Israel
- Rest of LAMEA
KEY MARKET PLAYERS
- F. Hoffmann-La Roche AG
- Seegene Inc.
- Cepheid
- Mylab Lifesolutions Pvt. Ltd.
- SureScreen Diagnostics Ltd
- Thermo Fisher Scientific
- Genematrix
- Robert Bosch GmbH
- Cellex